AR008290A1 - Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. - Google Patents
Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios.Info
- Publication number
- AR008290A1 AR008290A1 ARP970103665A ARP970103665A AR008290A1 AR 008290 A1 AR008290 A1 AR 008290A1 AR P970103665 A ARP970103665 A AR P970103665A AR P970103665 A ARP970103665 A AR P970103665A AR 008290 A1 AR008290 A1 AR 008290A1
- Authority
- AR
- Argentina
- Prior art keywords
- 4alkyl
- heterocycle
- heteroaryl
- procedure
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 title abstract 4
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 title abstract 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 239000005557 antagonist Substances 0.000 title 1
- 102000010681 interleukin-8 receptors Human genes 0.000 title 1
- 108010038415 interleukin-8 receptors Proteins 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- -1 C1-4alkyl-aryl Chemical group 0.000 abstract 1
- 102000019034 Chemokines Human genes 0.000 abstract 1
- 108010012236 Chemokines Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 1
- 108090001007 Interleukin-8 Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 abstract 1
- 229940096397 interleukin-8 Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describen compuestos que contienen guanidina de la fórmula (I), a composiciones farmacéuticas útiles en el tratamiento de estados deenfermedades mediadas por la quimioquina, interleuquina-8(il-8), así como a un procedimiento parapreparar compuestos intermediarios. Los compuestos defórmula (I) están representados por la estructura; en la que Z es ciano, OR11, C(O)NR15R16, R18, C(O)R11 o S(O)2R17; W es (II), R es cualquier resto funcionalque tiene hidrógeno ionizable y unpKa de 10 o inferiorr, R11 es hidrógeno, alquilo C1-4, arilo, alquil C1-4-arilo, heteroarilo, alquil C1-4, heteroariloopcionalmente sustituido, heterociclo o alquil C1-4-heterociclo; R15 y R16 son independientemente hidrógeno, alquilo C1-4,arilo, alquil C 1-4-arilo,heteroarilo, alquil C1-4, heteroarilo, heterociclo, alquilo C1-4-heterocilo, o R15 y R16 junto con el nitrógeno al que están unidos pueden formar un anillo de5 a 7 miembros que contiene opcionalmente un heteroátomoadicional s eleccionado entre oxígeno, nitrógeno o azufre; R17 es alquilo C1-4, NR15R16,OR11, arilo, heteroarilo, heteociclo, o alquil C1-4-heteroarilo, heterociclo o alquilC1-4-heterociclo, el anillo que contiene E se seleccionaopcionalmenteentre fórmula (III ), y siendo el asterisco el punto de unión del anillo, w que figura en la fórmula (IV) o sus sal farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2341496P | 1996-08-15 | 1996-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008290A1 true AR008290A1 (es) | 1999-12-29 |
Family
ID=21814968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103665A AR008290A1 (es) | 1996-08-15 | 1997-08-12 | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6204294B1 (es) |
| EP (1) | EP0929302A4 (es) |
| JP (1) | JP2000516619A (es) |
| KR (1) | KR20000030003A (es) |
| CN (1) | CN1152675C (es) |
| AR (1) | AR008290A1 (es) |
| AU (1) | AU723816B2 (es) |
| BR (1) | BR9711140A (es) |
| CA (1) | CA2263388A1 (es) |
| CO (1) | CO5031286A1 (es) |
| CZ (1) | CZ46799A3 (es) |
| IL (1) | IL128501A0 (es) |
| NO (2) | NO312458B1 (es) |
| PL (1) | PL331539A1 (es) |
| TR (1) | TR199900318T2 (es) |
| TW (1) | TW461878B (es) |
| WO (1) | WO1998006397A1 (es) |
| ZA (1) | ZA977301B (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0906273B1 (en) | 1996-05-24 | 2002-10-16 | Neurosearch A/S | Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| EP0932405A4 (en) | 1996-06-27 | 2001-10-17 | Smithkline Beckman Corp | IL-8 RECEPTOR ANTAGONISTS |
| US6335352B1 (en) * | 1996-08-15 | 2002-01-01 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| CA2245224A1 (en) * | 1998-08-14 | 2000-02-14 | Jiang-Hong Giong | Chemokine receptor antagonists and chemotherapeutics |
| CA2305787A1 (en) * | 2000-05-09 | 2001-11-09 | The University Of British Columbia | Cxcr4 antagonist treatment of hematopoietic cells |
| EP1061944B1 (en) | 1998-03-13 | 2004-01-28 | The University Of British Columbia | Therapeutic chemokine receptor antagonists |
| AR029361A1 (es) * | 1999-05-28 | 2003-06-25 | Smithkline Beecham Corp | Compuestos de guanidina ciclicas antagonistas de los receptores de la il- 8, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento |
| AR029637A1 (es) | 1999-05-28 | 2003-07-10 | Smithkline Beecham Corp | Compuestos de guanidina, antagonistas de los receptores de la il-8, una composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de un medicamento |
| ECSP003525A (es) * | 1999-06-16 | 2002-01-25 | Smithkline Beecham Corp | Antagonistas del receptor de il- 8 iv |
| UY26627A1 (es) | 2000-03-24 | 2001-09-28 | Smithkline Beecham Corp | Antagonistas de receptores de il-8 |
| US7378098B2 (en) * | 2000-04-12 | 2008-05-27 | The University Of British Columbia | CXC chemokine receptor 4 agonist peptides |
| US7368425B2 (en) * | 2006-03-24 | 2008-05-06 | Chemokine Therapeutics Corp. | Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
| US20050059584A1 (en) * | 2002-08-16 | 2005-03-17 | Ahmed Merzouk | Novel chemokine mimetics synthesis and their use |
| CA2335109A1 (en) * | 2000-04-12 | 2001-10-12 | Chemokine Therapeutics Corporation | Cxcr4 agonist treatment of hematopoietic cells |
| AU2001248753B2 (en) | 2000-04-14 | 2004-12-23 | Kureha Corporation | Nitrogenous compounds and antiviral drugs containing the same |
| US6515001B2 (en) | 2001-03-05 | 2003-02-04 | Chemokine Therapeutic Corporation | IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| CN1630517A (zh) * | 2001-05-24 | 2005-06-22 | 吴羽化学工业株式会社 | 包含含氮化合物的具有cxcr4拮抗作用的药物 |
| AU2003261974A1 (en) * | 2002-09-11 | 2004-04-30 | Kureha Chemical Industry Company, Limited | Amine compounds and use thereof |
| MY143477A (en) * | 2002-10-29 | 2011-05-31 | Smithkline Beecham Corp | Il-8 receptor antagonists |
| JP3977411B2 (ja) | 2004-03-10 | 2007-09-19 | 株式会社クレハ | アミン系塩基性化合物とその用途 |
| EP1745032B1 (en) | 2004-05-12 | 2013-07-31 | Merck Sharp & Dohme Corp. | CXCR1 and CXCR2 chemokine antagonists |
| EP1634573A1 (en) * | 2004-08-16 | 2006-03-15 | The Procter and Gamble Company | 2-(Amino or substituted Amino)-5,6-substituted Phenol compounds, dyeing compositions containing them, and use thereof |
| CN101039652A (zh) * | 2004-08-16 | 2007-09-19 | 宝洁公司 | 2－(氨基或取代的氨基)－5,6－取代的苯酚化合物，包含该化合物的染料组合物以及它们的应用 |
| US20070249625A1 (en) * | 2004-10-20 | 2007-10-25 | Jakob Busch-Petersen | Il-8 Receptor Antagonists |
| MX2008013599A (es) * | 2006-04-21 | 2008-10-31 | Smithkline Beechman Corp | Antagonistas del receptor il-8. |
| PT2009992E (pt) * | 2006-04-21 | 2012-09-06 | Glaxosmithkline Llc | Antagonistas de receptores da il-8 |
| CL2007001829A1 (es) * | 2006-06-23 | 2008-01-25 | Smithkline Beecham Corp | P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US537186A (en) * | 1895-04-09 | Jacob ebert | ||
| US4269837A (en) * | 1980-02-19 | 1981-05-26 | Pfizer Inc. | Hypoglycemic guanylamidines, compositions and use |
| NZ229828A (en) * | 1988-08-09 | 1992-03-26 | Squibb & Sons Inc | Aryl cyanoguanidine derivatives and pharmaceutical compositions |
| JP2742084B2 (ja) * | 1989-03-13 | 1998-04-22 | キヤノン株式会社 | グアニジン二量化物およびグアニジン二量化物を含有する静電荷像現像用トナー |
| US5214208A (en) * | 1989-03-13 | 1993-05-25 | Canon Kabushiki Kaisha | Toner containing a dimer of diarylguanidine type compound for developing electrostatic image |
| US5792444A (en) * | 1989-05-09 | 1998-08-11 | The General Hospital Corporation | Labeled chemotactic peptides to image focal sites of infection or inflammation |
| US5371086A (en) | 1991-03-15 | 1994-12-06 | The Green Cross Corporation | Aminopyridine compounds |
| AU4530693A (en) | 1992-08-13 | 1994-03-15 | Upjohn Company, The | Cyanoguanidines as potassium channel blockers |
| DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
| US5401758A (en) * | 1993-10-07 | 1995-03-28 | Bristol-Myers Squibb Company | Pyridinyl cyanoguanidine compounds |
-
1997
- 1997-08-12 AR ARP970103665A patent/AR008290A1/es not_active Application Discontinuation
- 1997-08-14 ZA ZA9707301A patent/ZA977301B/xx unknown
- 1997-08-15 KR KR1019997001283A patent/KR20000030003A/ko not_active Ceased
- 1997-08-15 CA CA002263388A patent/CA2263388A1/en not_active Abandoned
- 1997-08-15 EP EP19970938425 patent/EP0929302A4/en not_active Withdrawn
- 1997-08-15 JP JP10510106A patent/JP2000516619A/ja not_active Ceased
- 1997-08-15 US US09/230,977 patent/US6204294B1/en not_active Expired - Fee Related
- 1997-08-15 IL IL12850197A patent/IL128501A0/xx unknown
- 1997-08-15 TR TR1999/00318T patent/TR199900318T2/xx unknown
- 1997-08-15 PL PL97331539A patent/PL331539A1/xx unknown
- 1997-08-15 AU AU40750/97A patent/AU723816B2/en not_active Ceased
- 1997-08-15 CO CO97047171A patent/CO5031286A1/es unknown
- 1997-08-15 CZ CZ99467A patent/CZ46799A3/cs unknown
- 1997-08-15 BR BR9711140A patent/BR9711140A/pt not_active Application Discontinuation
- 1997-08-15 WO PCT/US1997/014581 patent/WO1998006397A1/en not_active Ceased
- 1997-08-15 CN CNB971986037A patent/CN1152675C/zh not_active Expired - Fee Related
- 1997-10-03 TW TW086111871A patent/TW461878B/zh not_active IP Right Cessation
-
1999
- 1999-02-12 NO NO19990668A patent/NO312458B1/no not_active IP Right Cessation
-
2001
- 2001-12-12 NO NO20016067A patent/NO314301B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL331539A1 (en) | 1999-07-19 |
| NO20016067D0 (no) | 2001-12-12 |
| TW461878B (en) | 2001-11-01 |
| AU723816B2 (en) | 2000-09-07 |
| JP2000516619A (ja) | 2000-12-12 |
| CZ46799A3 (cs) | 1999-12-15 |
| NO312458B1 (no) | 2002-05-13 |
| US6204294B1 (en) | 2001-03-20 |
| CA2263388A1 (en) | 1998-02-19 |
| NO20016067L (no) | 1999-04-12 |
| ZA977301B (en) | 1998-02-16 |
| NO990668L (no) | 1999-04-12 |
| NO314301B1 (no) | 2003-03-03 |
| CN1232398A (zh) | 1999-10-20 |
| NO990668D0 (no) | 1999-02-12 |
| IL128501A0 (en) | 2000-01-31 |
| KR20000030003A (ko) | 2000-05-25 |
| TR199900318T2 (xx) | 1999-05-21 |
| WO1998006397A1 (en) | 1998-02-19 |
| BR9711140A (pt) | 1999-08-17 |
| EP0929302A4 (en) | 2002-10-31 |
| AU4075097A (en) | 1998-03-06 |
| CN1152675C (zh) | 2004-06-09 |
| EP0929302A1 (en) | 1999-07-21 |
| CO5031286A1 (es) | 2001-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008290A1 (es) | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. | |
| CO5390075A1 (es) | Derivados de pirrilidinona | |
| ES2100907T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion. | |
| AR065937A2 (es) | Compuesto derivado indazol, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de proteina quinasa | |
| PE20020593A1 (es) | Activadores de glucocinasa del tipo isoindolin-2-ona | |
| RU94030476A (ru) | Производные пиперазина, способ их получения и фармацевтическая композиция | |
| ES2079576T3 (es) | Derivados piranicos biciclicos y su uso como inhibidores de 5-lipoxigenasa. | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| IT1152287B (it) | Pirrolidin-derivati | |
| MX9307946A (es) | Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso. | |
| ES2127789T3 (es) | Derivados de 1,2,4-triazol 4-sustituidos. | |
| ES557664A0 (es) | Un procedimiento para la sintesis de derivados de imidazol. | |
| ES8608792A1 (es) | Procedimiento para la preparacion de una composicion pesti- cida | |
| ES2044901T3 (es) | Procedimiento para la preparacion de un derivado de imidazol y su utilizacion. | |
| KR910000614A (ko) | 신규 화합물 | |
| ES2107505T3 (es) | Derivados de bencimidazol, un metodo para producirlo, fungicidas agricolas y horticolas que lo contienen como ingrediente activo y compuestos intermedios en su preparacion. | |
| FI903936A0 (fi) | Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl. | |
| KR930017894A (ko) | 살충제 조성물 | |
| ES9000005A1 (es) | Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos | |
| ATE76405T1 (de) | 2-trifluormethyl-benzimidazole. | |
| ES8403887A1 (es) | Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles | |
| NO872832D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| DE69112070D1 (de) | Anthelmintische und coccidizide 3-carbamoyl-4-hydroxycumarine, ihre verwendung und zusammensetzungen. | |
| AR027035A1 (es) | Pirroles sustituidos | |
| ES8707548A1 (es) | Un procedimiento para preparar compuestos peptidicos sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |